See MP/H rules on the slides if you do not have your manual.

Similar documents
7 th Edition Staging. AJCC 7 th Edition Staging. Disease Site Webinar. Melanoma of Skin. Overview. This webinar is sponsored by

Melanoma. Edward Buckingham, M.D. Combined Plastics & Otolaryngology Conference The University of Texas Medical Branch September 6, 2000

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

GENERAL CODING. When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis.

Kidney Cancer OVERVIEW

An individual is considered an incident case only once per lifetime.

Melanoma The Skin Understanding Cancer

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

General Rules SEER Summary Stage Objectives. What is Staging? 5/8/2014

Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis?

Understanding Your Surgical Options For Breast Cancer

OBJECTIVES By the end of this segment, the community participant will be able to:

RESEARCH EDUCATE ADVOCATE. Just Diagnosed with Melanoma Now What?

Melanoma: assessment and management of melanoma

Chapter 2 Staging of Breast Cancer

THYROID CANCER. I. Introduction

Male breast cancer - Wikipedia, the free encyclopedia

Sentinel Lymph Node Mapping for Endometrial Cancer. Locke Uppendahl, MD Grand Rounds

Current Status and Perspectives of Radiation Therapy for Breast Cancer

Collaborative Staging: Identifying Common Coding Discrepancies

Thyroid and Adrenal Gland

Oklahoma Facts CPT. Definitions. Mohs Micrographic Surgery. What Does That Mean? Billing and Coding for Mohs Surgery

Treating Melanoma S kin Cancer A Quick Guide

Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy

A912: Kidney, Renal cell carcinoma

SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD

Malcolm Mattes, MD Ajay Tejwani, MD, MPH New York Methodist Hospital

Revised U.K. guidelines for the management of cutaneous melanoma 2010

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER

9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH

Cervical Cancer The Importance of Cervical Screening and Vaccination

Coding Dermatology Procedures. Presented by: Betty A Hovey Director, ICD-10 Development and Training AAPC

The TV Series. INFORMATION TELEVISION NETWORK

Recommendations for cross-sectional imaging in cancer management, Second edition

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project

These rare variants often act aggressively and may respond differently to therapy than the more common prostate adenocarcinoma.

BREAST CANCER PATHOLOGY

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Breast Cancer. Sometimes cells keep dividing and growing without normal controls, causing an abnormal growth called a tumor.

The Diagnosis of Cancer in the Pathology Laboratory

The common feature of all melanomas is the cell of origin, the

How CanCer becomes critical in the claims

Melanoma Skin Cancer

Breast Cancer. CSC Cancer Experience Registry Member, breast cancer

How To Treat A Uterine Sarcoma

Diagnosis and Prognosis of Pancreatic Cancer

Treatment Part Two 1 FLORIDA CANCER DATA SYSTEM Treatment - Part Two

Your Guide to the Breast Cancer Pathology Report

Directly Coded Summary Stage Is Back

Understanding your pathology report

FRIEND TO FRIEND CPT CODES Diagnostic digital breast tomosynthesis, unilateral (list separately in addition to code for primary procedure)

Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data

Post-PET Restaging Cancer Form National Oncologic PET Registry

Surgical guidelines for the management of breast cancer

Lesions, and Masses,

dedicated to curing BREAST CANCER

Frequently Asked Questions About Ovarian Cancer

Integumentary System Individual Exercises

Melanoma. Understanding your diagnosis

ST JOSEPH REGIONAL HEALTH CENTER LUNG CANCER ANALYSIS Incidence, Diagnosis, Treatment and Survival

Protocol applies to melanoma of cutaneous surfaces only.

Clear Cell Sarcoma of the Foot: A Case Report of Malignant Melanoma of Soft Parts

Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科

Lung Cancer Treatment Guidelines

Melanoma Skin Cancer

Management of Postmenopausal Women with T1 ER+ Tumors: Options and Tradeoffs. Case Study. Surgery. Lumpectomy and Radiation

Prostate Cancer In-Depth

Tubular breast cancer

Breast Cancer. The Pathology report gives an outline on direction of treatment. It tells multiple stories to help us understand the patient s cancer.

Protocol for the Examination of Specimens from Patients with Melanoma of the Skin

Oncology Annual Report: Prostate Cancer 2005 Update By: John Konefal, MD, Radiation Oncology

Case Number: RT (M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor

Early Prostate Cancer: Questions and Answers. Key Points

Us TOO University Presents: Understanding Diagnostic Testing

Lesions, and Masses, and Tumors Oh My!!

Breast Health Starts Here

Your Guide to Express Critical Illness Insurance Definitions

Metastatic Melanoma of Unknown Primary: A Unique Entity? November 2012

Introduction. Case History

The Revised Melanoma Staging System and the Impact of Mitotic Rate

Breast Cancer Screening

ADJUVANT RADIATION FOR MALIGNANT MELANOMA

Update on Mesothelioma

Multiple Primary and Histology Site Specific Coding Rules KIDNEY. FLORIDA CANCER DATA SYSTEM MPH Kidney Site Specific Coding Rules

Carcinoma of the vagina is a relatively uncommon disease, affecting only about 2,000 women in

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? Telephone

Understanding Metastatic Disease

Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too.

Report series: General cancer information

SIGNPOSTS. Along the Pathway of Prostate Cancer. Understanding Diagnostic Tests and Procedures to Monitor Prostate Cancer

Male. Female. Death rates from lung cancer in USA

Cancer of the Cervix

WHAT S NEW: MARCH 12. REGISTRATION ONLINE: register.pl

The Ontario Cancer Registry moves to the 21 st Century


What You Need to Know Before Treatment About: Breast Cancer

LYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis

Mesothelioma , The Patient Education Institute, Inc. ocft0101 Last reviewed: 03/21/2013 1

Transcription:

Quiz 1 1. Which of the following statements about the incidence of melanoma in the US over the last 30 years is true? a. Melanoma incidences have been going down for both men and women. b. Melanoma incidences have been going up for men, but down for women c. Melanoma incidences have been going down for men, but up for women have been going down. d. Melanoma incidences have been going up for both men and women. 2. Which of the following sites is not considered paired? a. Skin of the external ear (C44.2) b. Skin of the scalp (C44.4) c. Skin of the trunk (C44.5) d. Skin of the arm (C44.7) 3. Which of the following statements about superficial spreading melanoma is false? a. Accounts for nearly 70% of all melanoma cases b. Usually has a radial growth phase before a vertical growth phase c. Is the most aggressive type of melanoma d. Often arises from pigmented nevus 4. A subungual melanoma a. Is not reportable b. Indicates a melanoma occurring under a finger nail or toe nail c. Is associated with superficial spreading melanoma d. Indicates a melanoma occurring in the eye 5. Which of the following is not an important prognostic factor for melanoma? a. Thickness of the tumor b. Ulceration c. Mitotic rate d. Color of the lesion 6. Which patients with a distant metastasis have the best prognosis? a. Metastasis to distant lymph nodes and a normal LDH b. Metastasis to the lung and a normal LDH c. Metastasis to the distant lymph nodes and an elevated LDH d. Metastasis to the liver and an elevated LDH

A patient presented with an enlarged axillary lymph node. This was excised and pathology revealed metastatic melanoma. A thorough exam failed to identify the primary or any further metastasis. 7. The primary site for this case would be a. Skin of the axilla (C44.5) b. Axillary lymph node (C77.3) c. Skin, Nos (C44.9) d. Unknown primary (C80.9) 8. The metastatic axillary lymph node would be coded in a. CS Ext b. CS Lymph Nodes c. CS Mets d. Cannot be included in CS coding. We don t know if it is regional or distant metastasis. See MP/H rules on the slides if you do not have your manual. 9. Pathology-final diagnosis-lentigo maligna with superficial spreading melanoma. Code the histology as a. Lentigo maligna (8742/2) b. Lentigo maligna melanoma (8742/3) c. Melanoma, nos (8720/3) d. Superficial spreading melanoma (8743/3) 10. Which of the following histologies would be coded as regressing melanoma (8723/3) a. Path-superficial spreading melanoma, regression present b. Path-malignant melanoma, lentigo melanoma type, level II. Regression present and prominent. c. Malignant melanoma with features of regression d. None of the above

Quiz 2 Axillary lymph node biopsy diagnosed metastatic malignant melanoma. An extensive skin search was performed, but no primary site of melanoma was identified. 1. What is the code for CS Tumor Size? a. 000: No mass/tumor found b. 999: Unknown; size not stated 2. What is the code for CS Extension? a. 950: No evidence of primary tumor b. 999: Unknown; extension not stated Punch biopsy left ankle: Clark level II malignant melanoma with microscopically positive margins; papillary-reticular dermis invasion. Wide excision of left ankle: no residual melanoma. 3. What is the code for CS Extension? a. 100: Papillary dermis invaded; Clark level II b. 200: Papillary-reticular dermal interface invaded; Clark level III c. 950: No evidence of primary tumor Wide excision of right upper arm lesion: Malignant Melanoma, Clark level IV; Breslow depth 3 mm. Right sentinel lymph node and in-transit metastasis biopsy: 1/13 lymph nodes positive for micrometastasis; 3/8 in-transit metastasis positive. Right axillary levels 1 and 2 lymph node dissection: 0/9 level 1 nodes; 0/3 level 2 nodes. 4. What is the code for CS Lymph Nodes? a. 100: Regional lymph nodes by primary site arm/shoulder axillary b. 151: Satellite nodules or in-transit metastases (distance from primary tumor not stated) WITHOUT regional lymph node involvement c. 200: Satellite nodules or in-transit metastases WITH regional lymph nodes listed in code 100 5. What is the code for Regional Nodes Positive? a. 01 b. 04 c. 33 d. 99: Unknown

6. What is the code for Regional Nodes Examined? a. 11 b. 13 c. 25 d. 33 Final diagnosis wide excision right upper back: Residual melanoma in-situ, Clark level I. Margins clear. 7. What is the code for SSF1 [Measured Thickness (Depth), Breslow Measurement]? a. 000: No mass/tumor found b. 999: Unknown 8. What is the code for SSF2 (Ulceration)? a. 000: No ulceration present b. 010: Ulceration present c. 999: Unknown PE: 2 cm left shoulder lesion, biopsy proven melanoma; palpable satellite lesion; no axillary lymphadenopathy. Wide excision of left shoulder lesion: residual melanoma, Clark II, Breslow depth 1 mm; 0.5 cm satellite lesion with melanoma. Sentinel lymph node biopsy: 1 of 3 axillary nodes with isolated tumor cells. 9. What is the code for SSF3 (Clinical Status of Lymph Node Mets)? a. 005: Clinically negative lymph node metastasis AND no pathologic exam performed or nodes negative on pathologic exam b. 010: Clinically occult (microscopic) lymph node metastasis only c. 100: Clinically apparent in transit metastasis only d. 150: Clinically apparent in transit metastasis and clinically apparent nodal metastasis (at least 1 node) Patient had melanoma of left calf. LDH level prior to wide excision of lesion was 95 U/L (45-90 U/L normal range for lab). Second test was not done. 10. What is the code for SSF4 (Serum LDH)? a. 000: Within normal limits b. 010: Range 1: Less than 1.5 x upper limit of normal c. 998: Test not done

11. What is the code for SSF5 (LDH Lab Value)? a. 095 b. 995: Stated as within normal limits, no further information in the chart c. 998: Test not done 12. What is the code for SSF6 (LDH Upper Limits of Normal)? a. 045 b. 090 c. 998: Test not done Final path diagnosis wide excision of mid back lesion: Malignant melanoma, localized, Breslow 1.3 mm. Mitotic count is 5 mitoses per 50 HPF. 13. What is the code for SSF 7 (Primary Tumor Mitotic Count/Rate)? a. 001 b. 005 c. 996: Mitotic rate described with denominator other than square mm Final path diagnosis wide excision of left abdominal lesion: Malignant melanoma confined to dermis, Breslow 4 mm. Regression is ruled out; however, vertical growth phase cannot be ruled out. 14. What is the code for SSF8 (Primary Tumor Regression)? a. 000: No regression present; regression not identified; regression absent b. 010: Regression present c. 998: No histologic exam of primary site 15. What is the code for SSF9 (Vertical Growth Phase VGP)? a. 000: No VGP present; VGP not identified; VGP absent b. 010: VGP present c. 998: No histologic exam of primary site

Quiz 3 1. If a melanoma is suspected, a physician will usually try to excise the lesion with margins of about a. 1-3mm b. 1cm c. 2cm d. More than 2cm 2. A punch biopsy with grossly positive margins would be coded as a. 02 Diagnostic Staging procedure b. 27 excisional biopsy c. 30 Biopsy of primary tumor followed by a gross excision of the lesion d. 32 Punch biopsy followed by a gross excision of the lesion 3. Patient had a punch biopsy followed by a wide excision. Per the pathology report the nearest surgical margin was 1cm from the melanoma. The wide excision would be coded as a. 27 excisional biopsy b. 30 Biopsy of primary tumor followed by a gross excision of the lesion c. 32 Punch biopsy followed by a gross excision of the lesion d. 46 Wide excision with margins more than 1 cm and less than or equal to 2 cm 4. A sentinel lymph node biopsy a. Can help identify metastasis to lymph nodes that are not clinically evident b. Can identify metastasis to lymph nodes in areas that are not typical lymph node drainage basins for the primary site c. Is not required for all melanomas d. All of the above 5. Interferon should be coded as a. Chemotherapy b. Biologic Response Modifier c. Hormone therapy d. Other treatment 27 Excisional biopsy 30 Biopsy of primary tumor followed by a gross excision of the lesion (does not have to be done underthe same anesthesia) 31 Shave biopsy followed by a gross excision of the lesion 32 Punch biopsy followed by a gross excision of the lesion 33 Incisional biopsy followed by a gross excision of the lesion Surgery Codes 45 Wide excision or reexcision of lesion or minor (local) amputation with margins more than 1 cm, NOS. Margins MUST be microscopically negative. 46 WITH margins more than 1 cm and less than or equal to 2 cm 47 WITH margins greater than 2 cm If the excision does not have microscopically negative margins greater than 1 cm, use the appropriate code, 20 36.